Akerna Corp.
Akerna Corp. (KERN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KERN · as of Jun 9, 2026
Key Statistics
Explore Akerna Corp. Data
kern stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 0.0%
Competitors & Peers
kern competitorsKERN
ATLN
BLPH
CMAX
HSTO
HUGEStock Performance
Full HistoryAbout Akerna Corp.
Akerna Corp. a Denver, Colorado-based company established in 2010, develops and provides sophisticated enterprise software solutions. These solutions primarily cater to businesses in the United State…
what is akerna corp. · kern stock overview · akerna corp. company profile · who is akerna corp. ceo · kern NASDAQ · akerna corp. headquarters · akerna corp. business segments
About Stock Overview & Key Data
Akerna Corp. (KERN) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Feb 26, 2018. As of the latest trading session, KERN stock price is $0.31, with a market capitalization of $162,320. The stock has returned -98.22% over the past 12 months and -95.93% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Akerna Corp. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Akerna Corp. reported revenue of $185164.00 and net income of -$153171.00. For detailed data — including Akerna Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Akerna Corp. (KERN) stock price is $0.31. The stock is traded on NASDAQ under the ticker symbol KERN. The 52-week range is $0.25 – $20.40.